RHO: First Wave selects Rho to manage adrulipase formulation trial
Rho will manage the Phase II clinical trial of the enhanced enteric microgranule delivery formulation of adrulipase. The post First Wave selects Rho to manage adrulipase formulation trial appeared first on Clinical Trials Arena.
Read full article »
Rho is a contract research organization with expertise, integrity, and passion for clinical research.
Read more